Sonoma Pharmaceuticals In... (SNOA)
NASDAQ: SNOA
· Real-Time Price · USD
2.94
0.00 (0.00%)
At close: Jun 24, 2025, 3:59 PM
2.91
-0.85%
After-hours: Jun 24, 2025, 05:38 PM EDT
0.00% (1D)
| Bid | 2.77 |
| Market Cap | 4.82M |
| Revenue (ttm) | 13.97M |
| Net Income (ttm) | -3.75M |
| EPS (ttm) | -2.79 |
| PE Ratio (ttm) | -1.05 |
| Forward PE | -1.65 |
| Analyst | n/a |
| Ask | 3.19 |
| Volume | 14,188 |
| Avg. Volume (20D) | 1,181,495 |
| Open | 2.96 |
| Previous Close | 2.94 |
| Day's Range | 2.91 - 2.96 |
| 52-Week Range | 1.75 - 9.40 |
| Beta | 1.40 |
About SNOA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SNOA
Website n/a
Earnings Surprise
Sonoma Pharmaceuticals has released their quartely earnings
on Jun 17, 2025:
2 months ago
+4.95%
Sonoma Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
3 months ago
+21.86%
Sonoma Pharmaceuticals shares are trading higher after the company announced it secured UK regulatory clearances for its key wound care and dermatology products.
1 week ago · accessnewswire.com
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial ResultsRevenues increased 9% in Q4 2025 compared to Q4 2024, and 12% in FY 2025 compared to FY 2024 Net loss improved 27% in Q4 2025 compared to Q4 2024, and 29% in FY 2025 compared to FY 2024 EBITDA loss im...
